Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering

Persistent infection with high-risk human papillomavirus (hrHPV) genotypes results in a large number of anogenital and head and neck cancers worldwide. Although prophylactic vaccination coverage has improved, there remains a need to develop methods that inhibit viral transmission toward preventing t...

Full description

Bibliographic Details
Main Authors: Joseph G. Skeate, Wouter H. Segerink, Mauricio D. Garcia, Daniel J. Fernandez, Ruben Prins, Kim P. Lühen, Féline O. Voss, Diane M. Da Silva, W. Martin Kast
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.561843/full
id doaj-95f0f794df68498dbee0a0c227fdac12
record_format Article
spelling doaj-95f0f794df68498dbee0a0c227fdac122020-11-25T03:42:19ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-09-011110.3389/fimmu.2020.561843561843Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid ClusteringJoseph G. Skeate0Wouter H. Segerink1Mauricio D. Garcia2Daniel J. Fernandez3Ruben Prins4Kim P. Lühen5Féline O. Voss6Diane M. Da Silva7Diane M. Da Silva8W. Martin Kast9W. Martin Kast10W. Martin Kast11Department of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesNorris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United StatesDepartment of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesNorris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United StatesDepartment of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesDepartment of Molecular Microbiology & Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesNorris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United StatesDepartment of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, CA, United StatesPersistent infection with high-risk human papillomavirus (hrHPV) genotypes results in a large number of anogenital and head and neck cancers worldwide. Although prophylactic vaccination coverage has improved, there remains a need to develop methods that inhibit viral transmission toward preventing the spread of HPV-driven disease. Defensins are a class of innate immune effector peptides that function to protect hosts from infection by pathogens such as viruses and bacteria. Previous work utilizing α and β defensins from humans has demonstrated that the α-defensin HD5 is effective at inhibiting the most common high-risk genotype, HPV16. A third class of defensin that has yet to be explored are θ-defensins: small, 18-amino acid cyclic peptides found in old-world monkeys whose unique structure makes them both highly cationic and resistant to degradation. Here we show that the prototype θ-defensin, rhesus theta defensin 1, inhibits hrHPV infection through a mechanism involving capsid clustering that inhibits virions from binding to cell surface receptor complexes.https://www.frontiersin.org/article/10.3389/fimmu.2020.561843/fullhuman papillomavirusalpha-defensinstheta-defensinsinfectioninnate-immunologysexually transmitted infection (STI)
collection DOAJ
language English
format Article
sources DOAJ
author Joseph G. Skeate
Wouter H. Segerink
Mauricio D. Garcia
Daniel J. Fernandez
Ruben Prins
Kim P. Lühen
Féline O. Voss
Diane M. Da Silva
Diane M. Da Silva
W. Martin Kast
W. Martin Kast
W. Martin Kast
spellingShingle Joseph G. Skeate
Wouter H. Segerink
Mauricio D. Garcia
Daniel J. Fernandez
Ruben Prins
Kim P. Lühen
Féline O. Voss
Diane M. Da Silva
Diane M. Da Silva
W. Martin Kast
W. Martin Kast
W. Martin Kast
Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering
Frontiers in Immunology
human papillomavirus
alpha-defensins
theta-defensins
infection
innate-immunology
sexually transmitted infection (STI)
author_facet Joseph G. Skeate
Wouter H. Segerink
Mauricio D. Garcia
Daniel J. Fernandez
Ruben Prins
Kim P. Lühen
Féline O. Voss
Diane M. Da Silva
Diane M. Da Silva
W. Martin Kast
W. Martin Kast
W. Martin Kast
author_sort Joseph G. Skeate
title Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering
title_short Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering
title_full Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering
title_fullStr Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering
title_full_unstemmed Theta-Defensins Inhibit High-Risk Human Papillomavirus Infection Through Charge-Driven Capsid Clustering
title_sort theta-defensins inhibit high-risk human papillomavirus infection through charge-driven capsid clustering
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-09-01
description Persistent infection with high-risk human papillomavirus (hrHPV) genotypes results in a large number of anogenital and head and neck cancers worldwide. Although prophylactic vaccination coverage has improved, there remains a need to develop methods that inhibit viral transmission toward preventing the spread of HPV-driven disease. Defensins are a class of innate immune effector peptides that function to protect hosts from infection by pathogens such as viruses and bacteria. Previous work utilizing α and β defensins from humans has demonstrated that the α-defensin HD5 is effective at inhibiting the most common high-risk genotype, HPV16. A third class of defensin that has yet to be explored are θ-defensins: small, 18-amino acid cyclic peptides found in old-world monkeys whose unique structure makes them both highly cationic and resistant to degradation. Here we show that the prototype θ-defensin, rhesus theta defensin 1, inhibits hrHPV infection through a mechanism involving capsid clustering that inhibits virions from binding to cell surface receptor complexes.
topic human papillomavirus
alpha-defensins
theta-defensins
infection
innate-immunology
sexually transmitted infection (STI)
url https://www.frontiersin.org/article/10.3389/fimmu.2020.561843/full
work_keys_str_mv AT josephgskeate thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT wouterhsegerink thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT mauriciodgarcia thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT danieljfernandez thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT rubenprins thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT kimpluhen thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT felineovoss thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT dianemdasilva thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT dianemdasilva thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT wmartinkast thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT wmartinkast thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
AT wmartinkast thetadefensinsinhibithighriskhumanpapillomavirusinfectionthroughchargedrivencapsidclustering
_version_ 1724525875969392640